CEO since 2021
Anders Hultman started his employment at AroCell 2018. He has more than 15 years’ experience in managerial and executive positions within finance, sales, and marketing. Furthermore, he has extensive international experience from several executive positions such as CFO, Sales Director, Product Marketing Director, and CEO in pharma, IT, telecom, and e-commerce companies. He has also worked as a journalist at Reuters and founded several companies. Anders has a Bachelor of Science in Business Administration and Economics from Uppsala University.
Holdings in AroCell: 165 000 shares.
Chief Commercial Officer since 2021
Michael is a business oriented and flexible leader with extensive experience from the Life science and pharmaceutical industry. Michael has been working at KabiGen, Pharmacia and Pharmacia & UpJohn performing development of pharmaceuticals at different management levels. Michael has also been working in Business Development plus sales and marketing at Biovitrum (today Sobi) and as Marketing Director at APL (Apotek Produktion & Laboratorier). Prior to joining AroCell, Michael was CEO of Karessa Pharma, a Clinical stage pharma development company in Sweden. Has a M Sc.
Holdings in AroCell: 195 790 shares.
Regulatory Affairs director since 2019
Peter Löwendahl has 30 years of experience working in regulatory affairs. He was previously responsible for quality and regulatory affairs at Elekta AB and globally responsible for regulatory affairs within GE Healthcare’s life science department. Peter Löwendahl has been working as a senior consultant and advisor for Hoff & Lowendahl AB since 2016.
Senior Sales Director sedan 2020
Marianne Alksnis has more than 20 years of international experience from business development and sales within the life science industry. Marianne has held various commercial positions at companies such as Karo Bio (today Karo Pharma), Biotage, Mercodia, and Calmark with a business focus on diagnostics and drug development. She also has experience as a business consultant working with the commercialization of innovations. Marianne has a BSc. in molecular biology and an MBA in international business management.
Holdings in AroCell: nil shares.
CMO since 2020
Gunnar Steineck has more than 30 years´ experience with research in the medical field. After studies in Mathematics, Statistics, and Medicine at Uppsala University he received training in oncology and radiotherapy at Karolinska University Hospital and became a specialist in 1990. After a Ph.D. exam (1990), Gunnar became an Associate Professor (1992) and subsequently did Post-doctoral studies at Memorial Sloan-Kettering Cancer Center in New York. In 2002 he was appointed Professor at Karolinska Institute and in 2004 he accepted a Professor’s Chair in Clinical Cancer Epidemiology at Gothenburg University. The focus of the recent research program was cure from cancer with restored health. Gunnar has more than 300 articles published in peer-reviewed journals covering studies of markers, randomized investigations, and large-scale observational data collections.
Professor Steineck’s strengths include a broad overview of the medical field together with thorough methodological insights concerning clinical research. He has given courses in clinical epidemiology and biostatistics for 25 years and has until recently held the position as Head of the Clinical Research School at Sahlgrenska Academy.
KIRAN KUMAR JAGARLAMUDI
Research Director since 2015
Kiran Kumar Jagarlamudi, PhD, is Clinical Research Manager at AroCell. He received his Bachelor’s Degree in Veterinary Sciences from the College of Veterinary Sciences, Hyderabad, India. He became Masters in Animal Science at the Swedish Agricultural University in Uppsala Sweden and obtained the degree of PhD in Veterinary Medicine (Biochemistry) in 2015 at the same institution. Since 2010, he has been working with different biochemical aspects of cellular and serum forms of thymidine kinase 1 (TK1) from both humans as well as dogs. He was also involved in the evaluation of early versions of AroCell TK 210 ELISA kits and characterization of TK1 antibodies.
Holdings in AroCell: 5 200 shares.
Marketing Director since 2019
Alona has studied the Master of Science in Molecular Biotechnology at Uppsala University, and Entrepreneurship at the School of Entrepreneurship. She has worked as a consultant at Uppstuk and Thermo Fischer Scientific before joining AroCell AB in 2017 as a Marketing and Sales Assistant.
Holdings in AroCell: 1000 shares.
Logistics Director since 2014
Filip Fogdestam is Head of Operations at AroCell since 2014. He runs a consultancy business, working with various life science start-ups since 2012. His experience includes Marketing Director and General Manager at MAIIA Diagnostics AB, and he has worked for MIAB AB and Phadia AB. He has also worked in the telecom sector. Filip has studied business administration at Uppsala University and the Swedish University of Agriculture and entrepreneurship and business acceleration in London, UK.
Holdings in AroCell: 314 928 shares.
Quality Assurance Director since 2014
Alf Malmberg (PhD) Manager QA&RA at AroCell has been working in the medical device business for 30 years. Mainly in Carmeda AB starting with product development and since 1987 QA&RA Manager. Since 2004 Alf Malmberg is Senior QA & RA Consultant, designing and implementing quality systems and technical files for small and medium sized companies.
Holdings in AroCell: 45 199 shares.